Advanced Search

 

Study ID Status Title Patient Level Data
LAM40089 Completed An International, Multicenter Double-Blind Randomised Comparative Trial of Lamotrigine and Slow Release Carbamazepine in Elderly Subjects with Newly Diagnosed Epilepsy.
LAM40090 Completed Valproate monotherapy conversion to lamotrigine monotherapy efficacy assessment in open-label, prospective 32-week study in children 2 -12 aged with epilepsy. The LAM40090 Study Group.
LAM40091 Completed Lamictal in Combination with Newer and Older Antiepileptic Drugs and as Monotherapy: A Practical Clinical Assessment of Tolerability and Clinical Effectiveness (The TARGET Study: Trial to Assess and Refine Global Epilepsy Treatment) Study Listed on ClinicalStudyDataRequest.com
LAM40096 Completed An open study comparing lamotrigine efficacy and safety in add-on treatment with carbamazepine or valproate and consecutive monotherapy in patients with resistant epilepsy
LAM40097 Completed A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Evaluation of Lamotrigine Adjunctive Therapy in Subjects wtih Primary Generalized Tonic-Clonic Seizures Study Listed on ClinicalStudyDataRequest.com
LAM40097_1 Completed A Multi-Center, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group, Evaluation of Lamotrigine Adjunctive Therapy in Subjects with Primary Generalized Tonic-Clonic Seizures [Data from the Open-label Continuation Phase] Study Listed on ClinicalStudyDataRequest.com
LAM40099 Completed An open, randomised, multicentre comparative trial of lamotrigine dispersible tablets and sodium-valproate-slow release as monotherapy in patients 60 years and older. Extensive searching has revealed that no clinical study report or publication is available for this study.
LAM40112 Completed Double-blind Randomized Trial of Cognitive Effects of LAMICTAL (lamotrigine) versus Topiramate in Epilepsy Study Listed on ClinicalStudyDataRequest.com
LAM40117 Completed A Multicenter, Open-Label, Pilot Study of Lamotrigine as Adjunctive Therapy and Monotherapy in Patients with Epilepsy and Comorbid Depressive Symptoms Study Listed on ClinicalStudyDataRequest.com
LAM40119 Completed An Open, Randomized, Multicenter Comparative Trial of Lamotrigine and Carbamazepine as Initial Monotherapy in Previously Untreated Epilepsies
LAM40120 Completed LAMOTRIGINE (Lamictal®) Treatment in adults with Attention Deficit Hyperactivity Disorder (ADHD), A pilot study.
LAM40123 Completed An open label, non-comparative, multicentre study to evaluate effectiveness and tolerability of Lamictal as first line monotherapy at the dose ranging from 25-200mg for 24 weeks in a flexible dosing regimen in senior/elderly newly diagnosed epileptic Malaysian patients having CT Scan abnormalities.
LAM40124 Completed An Assessment of Behavioral Changes Associated with Lamotrigine and Levetiracetam in Patients with Epilepsy Study Listed on ClinicalStudyDataRequest.com
Lamotrigine Suicidality Pooled Analysis Completed Analysis of data in lamotrigine clinical trials for suicidality
LAMPOL4002 Completed A multicentre, open study to estimate the effect of Lamivudine on liver histology and HBV DNA clearance in patients with chronic hepatitis B
LAMT07 Completed An open, multicentre study to evaluate the efficacy and safety of lamotrigine as add-on therapy in patients with myoclonic seizures and syndromes.
LB-01 Completed Dose Finding Study on Lamivudine in Chronic Hepatitis B Patients (Protocol LB01)
LB-02 Completed Phase III Study of Lamivudine - A Placebo-controlled, Double-blind Study of Lamivudine in Chronic Hepatitis B Patients - (Protocol No: LB-02)
LB-03 Completed Phase III Study of Lamivudine - A Long-term Study of Lamivudine in Chronic Hepatitis B Patients - (Protocol No: LB-03)
LB-04 Completed Phase III Clinical Trial of GG714 (Lamivudine): Histological Evaluation of Long-term Treatment - A Full Report of Extension Study - (Protocol No. LB-04)
LB-05 Completed Comparison of Pharmacokinetic of Lamivudine Between Elderly Volunteers and Healthy Young Male Volunteers (Protocol LB-05)
LB-06 Completed Phase III Study of Lamivudine - Follow-up Investigation after Double-blind Study (LB-02) and Long-term Study (LB-03) - (Protocol No.: LB-06)
LBI108245 Completed A multi-centre, observational study to evaluate the incidence of non-serious rash in Korean bipolar I patients with lamotrigine therapy in real world setting
LBI108614 Completed An open-label, randomised, single-dose, parallel-group study to evaluate the pharmacokinetic characteristics, safety and tolerability of up to two formulations (with different taste masking approaches) of an orally disintegrating tablet (ODT) of lamotrigine at 25mg and 200mg versus the immediate release (IR) lamotrigine in healthy subjects Study Listed on ClinicalStudyDataRequest.com
LBI108617 Completed An open-label, randomised, single-dose, parallel-group study to demonstrate bioequivalence of two formulations and the effect of food and water on one formulation of lamotrigine in healthy male and female volunteers Study Listed on ClinicalStudyDataRequest.com

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.